- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01639859
Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci (PROSTATE SSI)
May 23, 2019 updated by: Hospices Civils de Lyon
The primary aim of the study is to assess the elasticity (Young's modulus) of cancerous tumor foci, of normal peripheral zone, and of normal transition zone in the prostate.
Images obtained with the Supersonic Imagine Aixplorer scanner prior to radical prostatectomy are compared to whole-mount histology.
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon, France, 69 437
- Service de Radiologie, Pavillon P Radio, Hôpital Edouard Herriot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Patient over 18 years old, with prostate cancer and scheduled for radical prostatectomy
Exclusion Criteria:
- Medical history of prostate surgery or radiotherapy of prostate
- Medical history of abdominal perinéanal amputation or whole of state which prevent to use endorectal probe
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Elastography
|
The elastography in vivo will be performed before the prostatectomy.
The elastography ex vivo will be performed after radical prostatectomy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Young's modulus(kPa) of cancerous tumor foci
Time Frame: 2 years
|
2 years
|
Young's modulus(kPa) of normal peripheral zone
Time Frame: 2 years
|
2 years
|
Young's modulus(kPa) of normal transition zone
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ROUVIERE Olivier, Pr, Hospices Civils de Lyon
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (ACTUAL)
October 1, 2012
Study Completion (ACTUAL)
August 1, 2013
Study Registration Dates
First Submitted
June 22, 2012
First Submitted That Met QC Criteria
July 10, 2012
First Posted (ESTIMATE)
July 13, 2012
Study Record Updates
Last Update Posted (ACTUAL)
May 28, 2019
Last Update Submitted That Met QC Criteria
May 23, 2019
Last Verified
September 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2011.658
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer of Prostate
-
DendreonCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateAustria, France, Netherlands, United Kingdom
-
Roswell Park Cancer InstituteUniversity of PittsburghCompletedProstate Cancer | Prostate Neoplasms | Cancer of the Prostate | Neoplasms, Prostate | Prostatic Cancer | Neoplasms, Prostatic | Cancer of ProstateUnited States
-
Alliance Foundation Trials, LLC.Patient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of Prostate
-
Astellas Pharma IncAstellas Pharma US, Inc.CompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateNetherlands, United States, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterPatient-Centered Outcomes Research InstituteCompletedProstate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of ProstateUnited States
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Neoplasms of Prostate | Cancer Of Prostate | Prostate Neoplasms | Prostatic CancerUnited States
-
Nuvation Bio Inc.WithdrawnProstate Cancer | Prostate Neoplasm | Cancer of the Prostate | Prostatic Cancer | Castrate Resistant Prostate Cancer | Cancer of Prostate | Castration Resistant Prostatic Cancer | Castration Resistant Prostatic NeoplasmsUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Barbara Ann Karmanos Cancer InstituteGenentech, Inc.CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
Clinical Trials on Elastography
-
Istanbul UniversityCompletedAdenomyosis | Elastography | Transvaginal Ultrasound | Fibroid UterusTurkey
-
University Hospital, Basel, SwitzerlandActive, not recruiting
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Assiut UniversityNot yet recruitingSalivary Gland Diseases
-
National Taiwan University HospitalCompletedDonor Site Complication | Muscle; IschemicTaiwan
-
Abdelrahim ElsherbinyCompleted
-
National Taiwan University HospitalRecruiting